Edmond DE Rothschild Holding S.A. raised its position in Medtronic PLC (NYSE:MDT) by 2.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 174,632 shares of the medical technology company’s stock after buying an additional 3,405 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in Medtronic PLC were worth $14,069,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Jackson Grant Investment Advisers Inc. raised its position in shares of Medtronic PLC by 0.3% in the first quarter. Jackson Grant Investment Advisers Inc. now owns 2,920 shares of the medical technology company’s stock worth $235,000 after buying an additional 9 shares in the last quarter. Hudock Capital Group LLC raised its position in shares of Medtronic PLC by 0.6% in the first quarter. Hudock Capital Group LLC now owns 2,184 shares of the medical technology company’s stock worth $175,000 after buying an additional 12 shares in the last quarter. Delta Asset Management LLC TN raised its position in shares of Medtronic PLC by 0.4% in the first quarter. Delta Asset Management LLC TN now owns 3,713 shares of the medical technology company’s stock worth $299,000 after buying an additional 13 shares in the last quarter. Bollard Group LLC raised its position in shares of Medtronic PLC by 0.4% in the first quarter. Bollard Group LLC now owns 3,637 shares of the medical technology company’s stock worth $293,000 after buying an additional 14 shares in the last quarter. Finally, Tarbox Group Inc. raised its position in shares of Medtronic PLC by 0.4% in the first quarter. Tarbox Group Inc. now owns 5,180 shares of the medical technology company’s stock worth $417,000 after buying an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 83.36% of the company’s stock.

Medtronic PLC (NYSE:MDT) traded down 0.68% on Thursday, hitting $83.38. 527,838 shares of the company’s stock traded hands. The stock has a market cap of $113.32 billion, a P/E ratio of 28.85 and a beta of 1.02. The stock has a 50 day moving average price of $86.49 and a 200-day moving average price of $82.81. Medtronic PLC has a 12 month low of $69.35 and a 12 month high of $89.72.

Medtronic PLC (NYSE:MDT) last issued its quarterly earnings data on Thursday, May 25th. The medical technology company reported $1.33 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.31 by $0.02. The business had revenue of $7.92 billion for the quarter, compared to analysts’ expectations of $7.86 billion. Medtronic PLC had a return on equity of 12.72% and a net margin of 13.56%. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.27 EPS. Equities analysts predict that Medtronic PLC will post $4.81 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 26th. Stockholders of record on Friday, July 7th were issued a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a dividend yield of 2.19%. This is a boost from Medtronic PLC’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend was Wednesday, July 5th. Medtronic PLC’s dividend payout ratio is 63.67%.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/08/10/edmond-de-rothschild-holding-s-a-boosts-stake-in-medtronic-plc-nysemdt.html.

A number of equities analysts have weighed in on the stock. UBS AG reiterated a “buy” rating and set a $95.00 target price (up previously from $94.00) on shares of Medtronic PLC in a research report on Tuesday, May 30th. Jefferies Group LLC reiterated a “buy” rating and set a $103.00 target price on shares of Medtronic PLC in a research report on Thursday, August 3rd. CIBC reiterated a “buy” rating on shares of Medtronic PLC in a research report on Friday, May 26th. Barclays PLC reiterated an “overweight” rating and set a $94.00 target price (up previously from $92.00) on shares of Medtronic PLC in a research report on Sunday, May 28th. Finally, Cowen and Company reiterated an “outperform” rating and set a $95.00 target price (up previously from $86.00) on shares of Medtronic PLC in a research report on Sunday, May 28th. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the company’s stock. Medtronic PLC has an average rating of “Hold” and a consensus price target of $89.84.

In other news, EVP Bryan C. Hanson sold 12,000 shares of the company’s stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $88.57, for a total transaction of $1,062,840.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Richard H. Anderson acquired 5,600 shares of the firm’s stock in a transaction dated Wednesday, June 21st. The shares were purchased at an average cost of $88.90 per share, for a total transaction of $497,840.00. Following the completion of the acquisition, the director now directly owns 71,910 shares in the company, valued at $6,392,799. The disclosure for this purchase can be found here. 0.25% of the stock is owned by corporate insiders.

Medtronic PLC Company Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.